# Chromium Picolinate for the Treatment of Metabolic Syndrome

> **NCT00128154** · NA · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 60 (—)

## Conditions studied

- Metabolic Syndrome X
- Prediabetic State
- Insulin Resistance
- Obesity
- Metabolic Diseases

## Interventions

- **DRUG:** Chromium picolinate

## Key facts

- **NCT ID:** NCT00128154
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128154, "Chromium Picolinate for the Treatment of Metabolic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00128154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*